Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Moderna Therapeutics patent opposition analysis

Get Patent Opposition Report for Moderna Therapeutics

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Moderna Therapeutics

Explore patent oppositions filed by Moderna Therapeutics against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3115064	Rna-Coded Antibody	CUREVAC	Aug 24, 2022

Latest patents of Moderna Therapeutics opposed by its competitors

Explore Moderna Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP2791160	Mar 2, 2022	Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions	10
EP2922554	Feb 23, 2022	Terminally Modified Rna	1
EP3019619	Aug 25, 2021	Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use	2
EP3492109	Mar 4, 2020	Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof	2

Top competitors of Moderna Therapeutics

BIONTECH

CUREVAC

MAIWALD